Harry Bleiberg
Institut Jules Bordet
1 paper in the Anchorcite directory, published in 2004, cited 5,069 times in total.
Research topics
- Colorectal Cancer Treatments and Studies · 1 paper
- HER2/EGFR in Cancer Research · 1 paper
- Colorectal Cancer Surgical Treatments · 1 paper
Frequent co-authors
- David Cunningham · 1 paper
- Yves Humblet · 1 paper
- Salvatore Siena · 1 paper
- David Khayat · 1 paper
- Armando Santoro · 1 paper
- Danny Bets · 1 paper
- Matthias Mueser · 1 paper
- Andreas Harstrick · 1 paper
Papers
- Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal CancerNew England Journal of Medicine · 2004 · 5,069 citations
BACKGROUND: The epidermal growth factor receptor (EGFR), which participates in signaling pathways that are deregulated in cancer cells, commonly appears on colorectal-cancer cells. Cetuximab is a monoclonal antibody that specifically blocks the EGFR. We compared the efficacy of cetuximab in…
Metadata from OpenAlex (CC0).